๎
๎ผ
๋ก๊ทธ์ธ
๎
So-Young International Inc
SY2.650USD
-0.055-2.03%
์์ฅ ์ด์ ์๊ฐย ๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
221.86M์๊ฐ์ด์ก
์์คP/E TTM
๎
์์ธํ ๋ด์ฉ์ So-Young International Inc ํ์ฌ
So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website.
So-Young International Inc ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ SY
ํ์ฌ ์ด๋ฆSo-Young International Inc
์์ฅ์ผMay 02, 2019
CEOJin (Xing)
์ง์ ์1800
์ ํDepository Receipt
ํ๊ณ ์ฐ๋ ์ข
๋ฃMay 02
์ฃผ์2/F, East Tower, Poly Plaza, No. 66 Xiangbin Road, Chaoyang District
๋์BEIJING
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐChina
์ฐํธ ๋ฒํธ100102
์ ํ861087902012
์น์ฌ์ดํธhttps://www.soyoung.com/
์ข
๋ชฉ ์ฝ๋ SY
์์ฅ์ผMay 02, 2019
CEOJin (Xing)
So-Young International Inc์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Xing Jin
Mr. Xing Jin
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Haipeng Zhang, M.D.
Dr. Haipeng Zhang, M.D.
Independent Director
Independent Director
--
--
Prof. Chao He
Prof. Chao He
Independent Director
Independent Director
--
--
Mr. Xiaodong Ying
Mr. Xiaodong Ying
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Nan Huang
Mr. Nan Huang
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Hui Zhao
Mr. Hui Zhao
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Ms. Nan Shen
Ms. Nan Shen
Independent Director
Independent Director
--
--
Ms. Mona Qiao
Ms. Mona Qiao
Investor Relations
Investor Relations
--
--
Ms. Bei Wang
Ms. Bei Wang
Chief Marketing Officer
Chief Marketing Officer
--
--
Ms. Gefei Li
Ms. Gefei Li
Chief Operating Officer
Chief Operating Officer
--
--
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Xing Jin
Mr. Xing Jin
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Haipeng Zhang, M.D.
Dr. Haipeng Zhang, M.D.
Independent Director
Independent Director
--
--
Prof. Chao He
Prof. Chao He
Independent Director
Independent Director
--
--
Mr. Xiaodong Ying
Mr. Xiaodong Ying
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Nan Huang
Mr. Nan Huang
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Hui Zhao
Mr. Hui Zhao
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
์์ต ๋ถ์
ํตํ: USD๋ง์ง๋ง ์
๋ฐ์ดํธ: Tue, Jan 6
ํตํ: USD๋ง์ง๋ง ์
๋ฐ์ดํธ: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
์ฌ์
๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
Information services and other
998.81M
79.40%
Sales of equipment and maintenance services
259.07M
20.60%
์ง์ญ๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
China (Mainland)
1.47B
0.00%
์ฌ์
๋ณ
์ง์ญ๋ณ
์ฌ์
๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
Information services and other
998.81M
79.40%
Sales of equipment and maintenance services
259.07M
20.60%
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Feb 19
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Feb 19
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Matrix Partners China
9.56%
TB Alternative Assets Ltd.
3.63%
Barclays Bank PLC
1.32%
Citi Investment Research (US)
1.22%
Kadensa Capital Limited
1.21%
๊ธฐํ
83.07%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Matrix Partners China
9.56%
TB Alternative Assets Ltd.
3.63%
Barclays Bank PLC
1.32%
Citi Investment Research (US)
1.22%
Kadensa Capital Limited
1.21%
๊ธฐํ
83.07%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Venture Capital
9.63%
Investment Advisor
5.47%
Research Firm
3.34%
Hedge Fund
2.15%
Corporation
1.11%
Investment Advisor/Hedge Fund
0.77%
๊ธฐํ
77.52%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Jan 1
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Jan 1
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2025Q4
60
18.01M
21.43%
-2.31M
2025Q3
50
16.48M
19.69%
+799.52K
2025Q2
56
5.46M
6.45%
+3.53M
2025Q1
56
39.98M
47.25%
+2.34M
2024Q4
57
35.00M
40.69%
-4.68M
2024Q3
62
35.08M
40.78%
-22.79M
2024Q2
68
35.66M
41.41%
-22.81M
2024Q1
74
35.91M
41.67%
-24.80M
2023Q4
80
36.94M
43.37%
-24.33M
2023Q3
100
42.94M
49.19%
-27.05M
๋ ๋ณด๊ธฐ
์ฃผ์ฃผ ํ๋
๎์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
Matrix Partners China
8.09M
9.62%
-4.18M
-34.07%
Sep 30, 2025
TB Alternative Assets Ltd.
3.07M
3.65%
--
--
Sep 30, 2025
Barclays Bank PLC
497.63K
0.59%
-126.17K
-20.23%
Sep 30, 2025
Citi Investment Research (US)
675.12K
0.8%
+626.96K
+1301.89%
Sep 30, 2025
Kadensa Capital Limited
1.02M
1.22%
+1.02M
--
Sep 30, 2025
Morgan Stanley & Co. LLC
1.09M
1.3%
+1.08M
+7747.86%
Sep 30, 2025
Areo Holdings Ltd
709.77K
0.84%
--
--
Feb 28, 2025
Jane Street Capital, L.L.C.
218.24K
0.26%
+205.81K
+1655.06%
Sep 30, 2025
Beauty & Health Holdings Limited
233.07K
0.28%
+233.07K
--
Mar 31, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Dec 6
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Dec 6
์ด๋ฆ
๋น์จ
Invesco Golden Dragon China ETF
0.11%
SPDR S&P Emerging Markets Small Cap ETF
0.02%
Avantis Emerging Markets Small Cap Equity ETF
0.01%
SPDR S&P China ETF
0.01%
ActivePassive International Equity ETF
0%
Invesco Golden Dragon China ETF
๋น์จ0.11%
SPDR S&P Emerging Markets Small Cap ETF
๋น์จ0.02%
Avantis Emerging Markets Small Cap Equity ETF
๋น์จ0.01%
SPDR S&P China ETF
๋น์จ0.01%
ActivePassive International Equity ETF
๋น์จ0%
์ฃผ์ ๋ฐฐ๋น๊ธ
๎์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
๋ ์ง
๋ฐฐ๋น๊ธ
๊ธฐ์ค์ผ
์ง๊ธ์ผ
๋ฐฐ๋น๋ฝ์ผ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ถํ
๎๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
